[HTML][HTML] Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: A systematic review

D Jeremic, L Jiménez-Díaz, JD Navarro-López - Ageing research reviews, 2021 - Elsevier
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in ageing,
affecting around 46 million people worldwide but few treatments are currently available. The …

The genetic landscape of basal ganglia and implications for common brain disorders

S Bahrami, K Nordengen, J Rokicki, AA Shadrin… - Nature …, 2024 - nature.com
The basal ganglia are subcortical brain structures involved in motor control, cognition, and
emotion regulation. We conducted univariate and multivariate genome-wide association …

Resilience mechanisms underlying Alzheimer's disease

CS Chew, JY Lee, KY Ng, RY Koh, SM Chye - Metabolic Brain Disease, 2025 - Springer
Alzheimer's disease (AD) consists of two main pathologies, which are the deposition of
amyloid plaque as well as tau protein aggregation. Evidence suggests that not everyone …

Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk

AM Kulminski, I Philipp, L Shu, I Culminskaya - Neurobiology of aging, 2022 - Elsevier
Despite advances, the roles of genetic variants from the APOE-harboring 19q13. 32 region
in Alzheimer's disease (AD) remain controversial. We leverage a comprehensive approach …

Multi-modal imaging genetics data fusion by deep auto-encoder and self-representation network for Alzheimer's disease diagnosis and biomarkers extraction

CN Jiao, YL Gao, DH Ge, J Shang, JX Liu - Engineering Applications of …, 2024 - Elsevier
Alzheimer's disease (AD) is an incurable neurodegenerative disease, so it is important to
intervene in the early stage of the disease. Brain imaging genetics is an effective technique …

The ApoE locus and COVID-19: are we going where we have been?

CE Finch, AM Kulminski - The Journals of Gerontology: Series A, 2021 - academic.oup.com
Four decades ago in 1985, alleles of apolipoprotein E (ApoE) ε2/ε3/ε4 became famous for
explaining 16% of genetic variance in low-density lipoprotein cholesterol in the benchmark …

[PDF][PDF] Network medicine-based epistasis detection in complex diseases: ready for quantum computing

M Hoffmann, JM Poschenrieder, M Incudini… - Nucleic Acids …, 2024 - academic.oup.com
Most heritable diseases are polygenic. To comprehend the underlying genetic architecture,
it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic …

Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping

ME Belloy, SJ Eger, Y Le Guen, V Damotte… - Alzheimer's research & …, 2022 - Springer
Background Genetic variants within the APOE locus may modulate Alzheimer's disease (AD)
risk independently or in conjunction with APOE* 2/3/4 genotypes. Identifying such variants …

Haplotype architecture of the Alzheimer's risk in the APOE region via co‐skewness

AM Kulminski, I Philipp, Y Loika, L He… - Alzheimer's & …, 2020 - Wiley Online Library
Introduction As a multifactorial polygenic disorder, Alzheimer's disease (AD) can be
associated with complex haplotypes or compound genotypes. Methods We examined …

Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis

L Momkute, A Vilkeviciute, G Gedvilaite, G Dubinskaite… - Genes, 2022 - mdpi.com
Optical neuritis (ON), otherwise known as optical nerve damage, is a term used to describe
various environmental and body conditions that lead to optic nerve dysfunction. Neurologists …